ZipPrime ^None

ZipPrime is a biotechnology company that specializes in capturing, detection, and preservation of nucleic acid molecules. The company has developed a new, more efficient method for molecular targeting and capturing of oligonucleotides, including rare and fragile circulating-free DNA molecules. Their technology uses magnetic particle-based novel primer structures to capture each and every oligonucleotide molecule, allowing for accurate and low-cost solutions. ZipPrime's intellectual property is protected by a patent portfolio consisting of a patent family based upon a PCT application published in 2014, and their first patent was granted in February 2017.